Jacobs Levy Equity Management’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-84,342
Closed -$842K 975
2024
Q3
$842K Buy
84,342
+146
+0.2% +$1.46K ﹤0.01% 756
2024
Q2
$1.88M Sell
84,196
-4,108
-5% -$91.6K 0.01% 612
2024
Q1
$5.19M Sell
88,304
-11,276
-11% -$662K 0.02% 422
2023
Q4
$2.21M Sell
99,580
-2,705
-3% -$59.9K 0.01% 586
2023
Q3
$2.21M Buy
102,285
+62,396
+156% +$1.35M 0.01% 545
2023
Q2
$2.69M Sell
39,889
-4,876
-11% -$329K 0.02% 522
2023
Q1
$20.9M Sell
44,765
-12,300
-22% -$5.74M 0.13% 180
2022
Q4
$22.9M Sell
57,065
-156
-0.3% -$62.5K 0.15% 172
2022
Q3
$18.6M Sell
57,221
-1,086
-2% -$353K 0.15% 178
2022
Q2
$15.4M Sell
58,307
-365
-0.6% -$96.4K 0.12% 208
2022
Q1
$17.6M Buy
58,672
+3,215
+6% +$966K 0.12% 203
2021
Q4
$19.5M Buy
55,457
+15,466
+39% +$5.45M 0.13% 188
2021
Q3
$10.2M Buy
39,991
+896
+2% +$229K 0.07% 294
2021
Q2
$26M Buy
39,095
+37,416
+2,228% +$24.9M 0.18% 154
2021
Q1
$1.46M Sell
1,679
-3,213
-66% -$2.79M 0.01% 654
2020
Q4
$4.54M Sell
4,892
-2,833
-37% -$2.63M 0.04% 411
2020
Q3
$7.94M Buy
+7,725
New +$7.94M 0.08% 255
2020
Q2
Sell
-4,640
Closed -$4.03M 1071
2020
Q1
$4.03M Sell
4,640
-3,153
-40% -$2.74M 0.05% 332
2019
Q4
$8.36M Buy
7,793
+1,710
+28% +$1.83M 0.08% 279
2019
Q3
$5.62M Buy
6,083
+752
+14% +$695K 0.07% 316
2019
Q2
$6.02M Buy
+5,331
New +$6.02M 0.08% 307
2017
Q3
Sell
-3,533
Closed -$2.85M 974
2017
Q2
$2.85M Sell
3,533
-2,837
-45% -$2.29M 0.06% 353
2017
Q1
$3.93M Sell
6,370
-1,827
-22% -$1.13M 0.08% 296
2016
Q4
$4.39M Buy
8,197
+255
+3% +$136K 0.08% 273
2016
Q3
$4.11M Buy
7,942
+1,232
+18% +$638K 0.07% 296
2016
Q2
$2.75M Buy
6,710
+2,034
+43% +$835K 0.06% 362
2016
Q1
$2.49M Buy
+4,676
New +$2.49M 0.05% 360